Morgan Stanley
CTV.WS

Morgan Stanley’s Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share CTV.WS Stock Holding History

Morgan Stanley’s Portfolio CTV.WS Stock Details CTV.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-125
Closed – – 7988
2022
Q3 		$0 Hold
125
– – ﹤0.01% 7931
2022
Q2 		$0 Hold
125
– – ﹤0.01% 8032
2022
Q1 		$0 Buy
+125
New +$111 ﹤0.01% 8163

Other funds holding CTV.WS

BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
IAC
ION Acquisition Corp Herzliya, Israel $5.63M AUM 38.71% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
UM
Ulysses Management New York $802M AUM 5.35% 1-Year Est. Return

Morgan Stanley's CTV.WS Position: Q4 2022 in Review

Morgan Stanley sold out of Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share (CTV.WS) in Q4 2022, closing a stake of 125 shares.

Morgan Stanley first reported a position in CTV.WS in Q1 2022 and held it in 3 quarters. The position peaked at $0 in Q3 2022. 21 funds tracked by Wall St. Rank hold CTV.WS as of Q4 2022.

  • Morgan Stanley reported no remaining Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share position as of Q4 2022 after selling out during the quarter.
  • Morgan Stanley sold 125 Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share shares in Q4 2022.
  • Morgan Stanley first reported a position in Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share in Q1 2022 and held it in 3 quarters.
  • Morgan Stanley's Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share position peaked at $0 in Q3 2022.
  • 21 funds tracked by Wall St. Rank held Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share as of Q4 2022.

Based on Morgan Stanley's 13F filing for Q4 2022, filed 14 Feb 2023.